[Double blind comparison between imidazole-2-hydroxybenzoate and acetylsalicylic acid in the treatment of articular pain].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D011897:Random Allocation; D012459:Salicylates
D000893:Anti-Inflammatory Agents; D007093:Imidazoles; D012459:Salicylates; C043292:imidazole-2-hydroxybenzoate; D001241:Aspirin
Confronto a doppia cecitá tra imidzolo-2-idrossibenzoato e acido acetilsalicilico nel trattamento del dolore articolare.